A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...
The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.
Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an mRNA-based bird flu vaccine, health officials said.
A Nevada dairy worker who initially tested positive for bird flu is currently experiencing mild symptoms, including "pink eye ...
While the virus hasn’t made a sustained leap into humans, vaccines and treatments are being developed ahead of an outbreak.
The U.S. government will pay the vaccine maker Moderna $176 million to accelerate development of a pandemic influenza vaccine that could be used to treat bird flu in people, as concern grows about ...
To that end, HHS has granted Moderna $590 million to help accelerate the development of a bird flu vaccine. The agency announced its backing of the Massachusetts-based pharmaceutical firm about 72 ...
Waterfowl birds and their predators are especially at risk of contracting H5N1. Massachusetts has not yet reported a human ...
Bird flu has decimated poultry flocks and infected cattle herds. The risk to humans is currently low, but that could easily ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results